Medtronic Resolute Onyx 2.0 mm Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT02412501

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02412501
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02412501. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04-06 (actual); primary completion 2017-02-13 (actual). Results posted on 2018-04-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Medtronic Resolute Onyx 2.0 mm Clinical Study
Intervention (Device)
Resolute Onyx Stent - 2.0 mm
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct02412501
Content hash
5757cfe699de561bd45d8a8782c28012ecd3acc080ed67e7db01ababeeb60c31